Pacer Advisors, Inc. Karyopharm Therapeutics Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$8.11 - $11.11 $51,320 - $70,304	-6,328 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$9.85 - $17.69 $19,995 - $35,910	-2,030 Reduced 24.29%	6,328 $67,000
Q4 2020 Jan 20, 2021	BUY	$14.15 - $17.19 $29,233 - $35,514	2,066 Added 32.84%	8,358 $129,000
Q3 2020 Oct 19, 2020	BUY	$14.14 - $19.71 $88,968 - $124,015	6,292 New	6,292 $92,000
Q4 2018 Feb 13, 2019	SELL	$8.2 - $16.95 $39,893 - $82,461	-4,865 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.03 - $21.18 $82,850 - $103,040	4,865 New	4,865 $83,000

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.